CASP3 and neoplasm: Quantification analysis showed that caspase 3 positive rates in the tumor was significantly higher in YM155-treated mice than vehicle-treated mice (2.80% ± 0.11% vs 1.07 ± 0.15 %, p < 0.01) (Figure 6D).